TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biopharmacon, AB
Closing information (x1000 NOK)
| Closing information | 2023/06 | 2022/06 | 2021/06 |
| Turnover |
236
|
413 | |
| Financial expenses |
59
|
30 | |
| Earnings before taxes |
1,990
|
109 | |
| EBITDA |
16
|
101 | |
| Total assets |
6,583
|
4,861 | |
| Current assets |
6,175
|
4,376 | |
| Current liabilities |
65
|
108 | |
| Equity capital |
6,435
|
4,620 | |
| - share capital |
97
|
101 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Solvency |
97.8%
|
95.0% | |
| Turnover per employee |
236
|
413 | |
| Profit as a percentage of turnover |
843.2%
|
26.4% | |
| Return on assets (ROA) |
31.1%
|
2.9% | |
| Current ratio |
9500%
|
4051.9% | |
| Return on equity (ROE) |
30.9%
|
2.4% | |
| Change turnover |
-163
|
-318 | |
| Change turnover % |
57%
|
-41%
|
-43% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.